Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Christina Damoulari"'
Autor:
Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, Maria Kostoula, Maria Paneta, Georgios Adamis, Ilias Papanikolaou, Kimon Stamatelopoulos, Amalia Bolanou, Konstantinos Katsaros, Christina Delavinia, Ioannis Perdios, Aggeliki Pandi, Konstantinos Tsiakos, Nektarios Proios, Emmanouela Kalogianni, Ioannis Delis, Efstathios Skliros, Karolina Akinosoglou, Aggeliki Perdikouli, Garyfallia Poulakou, Haralampos Milionis, Eva Athanassopoulou, Eleftheria Kalpaki, Leda Efstratiou, Varvara Perraki, Antonios Papadopoulos, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/5b29b5166598467982ef661b72023eca
Autor:
Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, Maria Kostoula, Maria Paneta, Georgios Adamis, Ilias Papanikolaou, Kimon Stamatelopoulos, Amalia Bolanou, Konstantinos Katsaros, Christina Delavinia, Ioannis Perdios, Aggeliki Pandi, Konstantinos Tsiakos, Nektarios Proios, Emmanouela Kalogianni, Ioannis Delis, Efstathios Skliros, Karolina Akinosoglou, Aggeliki Perdikouli, Garyfallia Poulakou, Haralampos Milionis, Eva Athanassopoulou, Eleftheria Kalpaki, Leda Efstratiou, Varvara Perraki, Antonios Papadopoulos, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
In a recent study of our group with the acronym ACTIVATE, Bacillus Calmete-Guérin (BCG) vaccination reduced the occurrence of new infections compared to placebo vaccination in the elderly. Most benefit was found for respiratory infections. The ACTIV
Externí odkaz:
https://doaj.org/article/5506fdf79b8e4383b25dc7754a7fcc23
Autor:
Maria Siopi, Antonios Papadopoulos, Anastasia Spiliopoulou, Fotini Paliogianni, Nissrine Abou-Chakra, Maiken Cavling Arendrup, Christina Damoulari, Georgios Tsioulos, Efthymia Giannitsioti, Frantzeska Frantzeskaki, Iraklis Tsangaris, Spyros Pournaras, Joseph Meletiadis
Publikováno v:
Journal of Fungi, Vol 8, Iss 9, p 931 (2022)
The isolation of a pan-echinocandin-resistant Candida parapsilosis strain (anidulafungin, caspofungin, micafungin and rezafungin EUCAST MICs > 8 mg/L) from urine of a patient following prolonged exposure to echinocandins (38 days of micafungin follow
Externí odkaz:
https://doaj.org/article/e8f59495d9e247b88c9f4b2edcaf12bc
Autor:
Panteleimon Tsiamalos, Iro Rapti, Androniki Papapostolou, Thomas Nitsotolis, Chrysanthi Sidiropoulou, Haralampos Milionis, Konstantinos N. Syrigos, Antonios Tsakiris, Konstantina Katrini, Eleftherios Klouras, Evangelos J. Giamarellos-Bourboulis, Emmanouil Vrentzos, George Chrysos, Georgios Tsibris, Periklis Panagopoulos, Dimitra-Melia Myrodia, Vagia Zarkada, Theologia Gkavogianni, Garyphallia Poulakou, Evangelos Michelakis, Konstantinos Tsiakos, Maria Georgiopoulou, Christina Damoulari, Vasileios Petrakis, Maria Kosmidou, Sofia Artemi, Areti Gravvani, Panagiotis Koufargyris, Pantazis-Michael Voutsinas, Anastasios Ioannidis, Athanassios Karageorgos
Publikováno v:
Infectious Diseases and Therapy
Introduction The anti-inflammatory effect of macrolides prompted the study of oral clarithromycin in moderate COVID-19. Methods An open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October
Autor:
Evdoxia Kyriazopoulou, Thomas Huet, Giulio Cavalli, Andrea Gori, Miltiades Kyprianou, Peter Pickkers, Jesper Eugen-Olsen, Mario Clerici, Francisco Veas, Gilles Chatellier, Gilles Kaplanski, Mihai G Netea, Emanuele Pontali, Marco Gattorno, Raphael Cauchois, Emma Kooistra, Matthijs Kox, Alessandra Bandera, Hélène Beaussier, Davide Mangioni, Lorenzo Dagna, Jos W M van der Meer, Evangelos J Giamarellos-Bourboulis, Gilles Hayem, Mihai G. Netea, Jos W.M. van der Meer, Evangelos J. Giamarellos-Bourboulis, Stefano Volpi, Maria Pia Sormani, Alessio Signori, Giorgio Bozzi, Francesca Minoia, Stefano Aliberti, Giacomo Grasselli, Laura Alagna, Andrea Lombardi, Riccardo Ungaro, Carlo Agostoni, Francesco Blasi, Giorgio Costantino, Anna Ludovica Fracanzani, Nicola Montano, Flora Peyvandi, Marcello Sottocorno, Antonio Muscatello, Giovanni Filocamo, Antonios Papadopoulos, Maria Mouktaroudi, Eleni Karakike, Maria Saridaki, Theologia Gkavogianni, Konstantina Katrini, Nikolaos Vechlidis, Christina Avgoustou, Stamatios Chalvatzis, Theodoros Marantos, Christina Damoulari, Georgia Damoraki, Sofia Ktena, Maria Tsilika, Panagiotis Koufargyris, Athanasios Karageorgos, Dionysia-Irene Droggiti, Aikaterini Koliakou, Garyfallia Poulakou, Konstantinos Tsiakos, Dimitra-Melia Myrodia, Areti Gravvani, Ioannis P. Trontzas, Konstantinos Syrigos, Ioannis Kalomenidis, Eleftheria Kranidioti, Periklis Panagopoulos, Vasileios Petrakis, Simeon Metallidis, Georgia Loli, Olga Tsachouridou, George N. Dalekos, Nikolaos Gatselis, Aggelos Stefos, Sarah Georgiadou, Vassiliki Lygoura, Haralampos Milionis, Maria Kosmidou, Ilias C. Papanikolaou, Karolina Akinosoglou, Efthymia Giannitsioti, Georgios Chrysos, Panagiotis Mavroudis, Chrysanthi Sidiropoulou, Georgios Adamis, Archontoula Fragkou, Aggeliki Rapti, Zoi Alexiou, Styliani Symbardi, Aikaterini Masgala, Konstantina Kostaki, Evangelos Kostis, Michael Samarkos, Petros Bakakos, Vassiliki Tzavara, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Vasileios Kotsis, George Tsoukalas, Ioannis Bliziotis, Michael Doumas, Aikaterini Argyraki, Ilias Kainis, Massimo Fantoni, Antonella Cingolani, Andrea Angheben, Chiara Simona Cardellino, Francesco Castelli, Francesco Saverio Serino, Emanuele Nicastri, Giuseppe Ippolito, Matteo Bassetti, Carlo Selmi
Publikováno v:
The Lancet. Rheumatology, 3, e690-e697
The Lancet Rheumatology
The Lancet Rheumatology, 2021, 3 (10), pp.e690-e697. ⟨10.1016/S2665-9913(21)00216-2⟩
The Lancet. Rheumatology
The Lancet. Rheumatology, 3, 10, pp. e690-e697
The Lancet Rheumatology
The Lancet Rheumatology, 2021, 3 (10), pp.e690-e697. ⟨10.1016/S2665-9913(21)00216-2⟩
The Lancet. Rheumatology
The Lancet. Rheumatology, 3, 10, pp. e690-e697
Contains fulltext : 237989.pdf (Publisher’s version ) (Closed access) BACKGROUND: Anakinra might improve the prognosis of patients with moderate to severe COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support).
Autor:
Konstantina Katrini, Panagiotis Koufargyris, Karolina Akinosoglou, Evangelos J. Giamarellos-Bourboulis, Malvina Lada, Magdalini Kyriakopoulou, George Dimopoulos, Georgios Renieris, Christos Psarrakis, Christina Damoulari
Publikováno v:
Shock
Shock (Augusta, Ga.)
Shock (Augusta, Ga.)
Supplemental Digital Content is available in the text
Background: The pneumonia of COVID-19 illness has often a subtle initial presentation making mandatory the use of biomarkers for evaluation of severity and prediction of final patient disposi
Background: The pneumonia of COVID-19 illness has often a subtle initial presentation making mandatory the use of biomarkers for evaluation of severity and prediction of final patient disposi
Autor:
Chrysanthi Sidiropoulou, Evangelos Giamarellos-Bourboulis, Garyfallia Poulakou, Maria Tsilika, Spyros Foutadakis, Vassiliki Evangelopoulou, George Adamis, Aggeliki Rapti, Efthymia Giannitsioti, Styliani Symbardi, Nikoletta Charalampaki, Paraskevi Chra, Konstantinos Tsiakos, Giannis Vatsellas, Mervan Damadoglou, Petros Bakakos, Georgia Damoraki, Theologia Gkavogianni, Leda Efstratiou, Christina Damoulari, Konstantinos Leventogiannis, Achilleas Laskaratos, Anna Strikou, Panagiotis Koufargyris, Konstantina Katrini, Vassiliki Rapti, Aglaia Galanopoulou, Karolina Akinosoglou, Haralampos Milionis, Archontoula Fragkou, Dimitris Thanos, Periklis Panagopoulos, Zoi Alexiou, George N. Dalekos, Konstantinos N. Syrigos, Athanasios Ziogas, Rob ter Horst, Jos W.M. van der Meer, Mihai G. Netea, Evdoxia Kyriazopoulou
Publikováno v:
SSRN Electronic Journal.
Autor:
Panayiotis Koufargyris, Maria Mouktaroudi, Ilias Kainis, Styliani Symbardi, Spyridon Savvanis, Matteo Bassetti, Michael Samarkos, Periklis Panagopoulos, Dimitra-Melia Myrodia, Vassiliki Rapti, Konstantina Katrini, Giulio Cavalli, Eleni-Ioanna Katsigianni, Lorenzo Dagna, Mihai G. Netea, Evdoxia Kyriazopoulou, Massimo Fantoni, Carlo Selmi, Katerina Koliakou, Eleni Florou, Sofia Ktena, Vasileios Kotsis, Glykeria Tzatzagou, Evangelos Kostis, Vassiliki Tzavara, Francesco Castelli, Emanuele Nicastri, Styliani Micha, Ioannis Kalomenidis, Konstantinos Tsiakos, Aikaterini Masgala, Giuseppe Ippolito, Maria Kosmidou, George N Dalekos, Ioannis Bliziotis, Simeon Metallidis, Miltiades Kyprianou, Aggeliki Rapti, Archontoula Fragkou, Garyfallia Poulakou, Aikaterini Argyraki, Ilias Papanikolaou, Francesco Saverio Serino, George Tsoukalas, Maria Chini, Christina Damoulari, Karolina Akinosoglou, Evangelos J. Giamarellos-Bourboulis, Antonella Cingolani, Georgios Chrysos, Jesper Eugen-Olsen, Efthymia Giannitsioti, Andrea Angeheben, Chiara Simona Cardellino, Antigone Kotsaki, Zoi Alexiou, Katerina Dimakou, Michael Doumas, Georgios Adamis, Maria Tsilika, Haralampos J. Milionis, Petros Bakakos, Orestis Liatsis-Douvitsas, Nikolaos Gatselis
Early recognition of risk and start of treatment may improve unfavorable outcome of COVID-19. In the SAVE-MORE double-blind randomized trial, 594 patients with pneumonia without respiratory dysfunction at risk as defined by plasma suPAR (soluble urok
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::864aaa3bef64fcd164016b030878e280
https://doi.org/10.21203/rs.3.rs-646951/v1
https://doi.org/10.21203/rs.3.rs-646951/v1
Autor:
Ioannis Perdios, Maria Kostoula, Mihai G. Netea, Eleftheria Kalpaki, Varvara Perraki, Maria Paneta, Gerogios Adamis, Esther Taks, Emmanouela Kalogianni, Amalia Bolanou, Maria Tsilika, Haralampos J. Milionis, Leda Efstratiou, Kimon Stamatelopoulos, Efstathios Skliros, Nektarios Proios, Antonios Papadopoulos, Christina Damoulari, Konstantinos Leventogiannis, Antigone Kotsaki, Ioannis Delis, Christina Delavinia, Ilias Papanikolaou, Karolina Akinosoglou, Aggeliki Perdikouli, Konstantinos Tsiakos, Konstantinos Katsaros, Evangelos J. Giamarellos-Bourboulis, Konstantinos Dolianitis, Aggeliki Pandi, Garyfallia Poulakou, Eva Athanasopoulou
SUMMARYBCG vaccination induces heterologous protection against respiratory tract infections, and in children improves survival independently of tuberculosis prevention. The phase III ACTIVATE-2 study assessed whether BCG could also protect against CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31bf5e146451f5cc4603bb0fb724aab0
https://doi.org/10.1101/2021.05.20.21257520
https://doi.org/10.1101/2021.05.20.21257520
Autor:
Georgios Adamis, Maria Tsilika, Ilias Kainis, Haralampos J. Milionis, Orestis Liatsis-Douvitsas, Ioannis Bliziotis, Petros Bakakos, Vasileios Kotsis, Ilias Papanikolaou, Giulio Cavalli, Periklis Panagopoulos, Glykeria Tzatzagou, Evdoxia Kyriazopoulou, George N. Dalekos, Styliani Symbardi, Maria Kosmidou, Giuseppe Ippolito, Chiara Simona Cardellino, Spyridon Savvanis, Simeon Metallidis, Carlo Selmi, Katerina Koliakou, Aggeliki Rapti, Michael Samarkos, Aikaterini Argyraki, Christina Damoulari, Francesco Saverio Serino, Matteo Bassetti, Efthymia Giannitsioti, Katerina Dimakou, Vassiliki Tzavara, Sofia Ktena, Styliani Micha, Konstantinos Tsiakos, Francesco Castelli, Konstantina Katrini, Lorenzo Dagna, Antigone Kotsaki, Michael Doumas, Archontoula Fragkou, Massimo Fantoni, Vassiliki Rapti, Aikaterini Masgala, Panagiotis Koufargyris, George Tsoukalas, Jesper Eugen-Olsen, Mihai G. Netea, Maria Mouktaroudi, Eleni Florou, Eleni Ioanna Katsigianni, Antonella Cingolani, Andrea Angheben, Zoi Alexiou, Emanuele Nicastri, Nikolaos K. Gatselis, Maria Giovanna Chini, Ioannis Kalomenidis, Miltiades Kyprianou, Garyfallia Poulakou, Evangelos Kostis, Karolina Akinosoglou, Dimitra Melia Myrodia, Evangelos J. Giamarellos-Bourboulis, Georgios Chrysos
Publikováno v:
Nature Medicine, 27, 1752-1760
Nature Medicine
Nature Medicine, 27, 10, pp. 1752-1760
Nature Medicine
Nature Medicine, 27, 10, pp. 1752-1760
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to respiratory failure. The SAVE-MORE double-blind, randomized controlled tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcda29336a693e8d75e06da59bfd5bf5
http://hdl.handle.net/2066/245676
http://hdl.handle.net/2066/245676